Bell Investment Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$410 Hold
3
﹤0.01% 1770
2026
Q1
$354 Hold
3
﹤0.01% 1826
2025
Q4
$492 Hold
3
﹤0.01% 1749
2025
Q3
$402 Sell
3
-3
-50% -$364 ﹤0.01% 1815
2025
Q2
$747 Buy
6
+3
+100% +$382 ﹤0.01% 1674
2025
Q1
$382 Sell
3
-3
-50% -$462 ﹤0.01% 1830
2024
Q4
$864 Sell
6
-10
-63% -$1.43K ﹤0.01% 1623
2024
Q3
$2.38K Buy
16
+3
+23% +$430 ﹤0.01% 1278
2024
Q2
$1.64K Sell
13
-6
-32% -$940 ﹤0.01% 1447
2024
Q1
$3.5K Buy
19
+3
+19% +$571 ﹤0.01% 1098
2023
Q4
$2.88K Buy
16
+4
+33% +$623 ﹤0.01% 1175
2023
Q3
$1.91K Sell
12
-7
-37% -$1.14K ﹤0.01% 1296
2023
Q2
$2.69K Sell
19
-3
-14% -$481 ﹤0.01% 1145
2023
Q1
$3.7K Sell
22
-9
-29% -$1.61K ﹤0.01% 935
2022
Q4
$5.25K Sell
31
-3
-9% -$544 ﹤0.01% 784
2022
Q3
$6K Buy
34
+9
+36% +$1.9K ﹤0.01% 611
2022
Q2
$4K Buy
+25
New +$3.95K ﹤0.01% 840
2021
Q4
$6K Sell
23
-38
-62% -$10.2K ﹤0.01% 707
2021
Q3
$18K Buy
+61
New +$15.6K 0.01% 312

Other funds holding RGEN

Bell Investment Advisors's RGEN Position: Q2 2026 in Review

Bell Investment Advisors held its Repligen (RGEN) position steady in Q2 2026 at 3 shares worth $410. The position accounts for ﹤0.01% of the portfolio, ranked #1770.

Bell Investment Advisors first reported a position in RGEN in Q3 2021 and has held it in 19 quarters since. The position peaked at $18K in Q3 2021. 477 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Bell Investment Advisors held 3 shares of Repligen worth $410 as of Q2 2026.
  • Bell Investment Advisors left its Repligen share count unchanged in Q2 2026.
  • Repligen made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1770 holding.
  • Bell Investment Advisors first reported a position in Repligen in Q3 2021 and has held it in 19 quarters since.
  • Bell Investment Advisors's Repligen position peaked at $18K in Q3 2021.
  • 477 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.